Teva's $225 Million Opioid Deal With Texas Is Its Biggest (2)
Teva Is Exploring Mylan Bid to Create Generic-Drug Giant - Bloomberg
Watch Teva Makes Mylan Bid for $82 per Share - Bloomberg
TEVA: Teva Pharmaceutical Industries Ltd Stock Price Quote - New York - Bloomberg
Teva, Allergan Ready To Pay $5B To Settle Lawsuits Related To Opioid Painkillers: Bloomberg
Teva looks to sell generics in China through joint venture with Guangzhou Pharma: Bloomberg | Fierce Pharma
US states sue Teva for price-fixing in 'multi-billion dollar fraud' | The Times of Israel
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Teva CEO Vigodman Steps Down After Poor Outlook for 2017 | Fortune
Kare Schultz, president and chief executive officer of Teva... News Photo - Getty Images
Teva Pharmaceuticals (TEVA) Stock Gets Upgraded at HSBC - TheStreet
US states accuse Teva and other drugmakers of colluding to inflate prices over 1,000%
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Israel Not Aiming to Punish Teva on Job Cuts, Official Says - Bloomberg
Amid sales slump, Teva CEO Schultz's pay falls 7% to $14.7M | Fierce Pharma
Teva (TEVA) Agrees to $225 Million Texas Opioid Settlement, AG Says - Bloomberg
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York state - Local News 8
Teva's Trouble Was Predicted. Path to Recovery Not as Clear - Bloomberg
Glaxo/Teva Ruling Could Spell Trouble for Generic Drugmakers
Watch Mylan Board Rejects $40.1B Teva Takeover Bid - Bloomberg
Israeli Drugmaker Teva in Talks to Help Produce Covid-19 Vaccines
Teva Agrees to Stop Selling Amgen Generic Following Patent Infringement Settlement | Ctech
Analysis: Teva Pharmaceuticals is bogged down by legal issues, fails to kick-start growth | Ctech
Teva Pharmaceuticals CEO steps down as shares continue descent - BNN Bloomberg
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
